Correlation Between Sumitomo Dainippon and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both Sumitomo Dainippon and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Dainippon and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sumitomo Dainippon Pharma and Neurocrine Biosciences, you can compare the effects of market volatilities on Sumitomo Dainippon and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Dainippon with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Dainippon and Neurocrine Biosciences.

Diversification Opportunities for Sumitomo Dainippon and Neurocrine Biosciences

0.0

Correlation Coefficient

Sumitomo Dainippon  Neurocrine Biosciences

Pay attention - limited upside

The 3 months correlation between Sumitomo and Neurocrine is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Dainippon Pharma and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Sumitomo Dainippon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Dainippon Pharma are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Sumitomo Dainippon i.e., Sumitomo Dainippon and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between Sumitomo Dainippon and Neurocrine Biosciences

If you would invest (100.00) in Sumitomo Dainippon Pharma on December 31, 2024 and sell it today you would earn a total of  100.00  from holding Sumitomo Dainippon Pharma or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Sumitomo Dainippon Pharma  vs.  Neurocrine Biosciences

Sumitomo Dainippon Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sumitomo Dainippon Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sumitomo Dainippon is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Neurocrine Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Sumitomo Dainippon and Neurocrine Biosciences

The main advantage of trading using opposite Sumitomo Dainippon and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Dainippon position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind Sumitomo Dainippon Pharma and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.